The story of Trinov’s hair-loss lotion commences in 2010: it all started almost by chance, when Giovanni Brotzu, a doctor from Cagliari in Sardinia, was conducting a trial on a medicine for the treatment of diabetes. One of the consequences of this condition is that the capillaries retract causing a loss of microcirculation, which also results in a partial loss of body hair. This led to the revolutionary intuition regarding the association with hair loss in men and women and the start of the research that led to the creation of Fidia Farmaceutici’s hair-loss lotion.
The new study led to an innovative formulation based on the combined effect of three molecules that act on the scalp: Dihomo-gamma-linolenic acid (DGLA), which stimulates the microcirculation and tissue trophism; Equol, which counters the production of Dihydrotestosterone (DHT) and, lastly, L-Carnitine, which has a known energising action.
The many tests conducted confirm the effective results and so, in 2015, Fidia Farmaceutici formalises the purchase of the patent. As a result of the company’s on-going commitment to research, the new Fidia Farmaceutici hair-loss lotion finds its final formulation and is placed on the market under the trade name Trinov.